Universal Detection Technology, NASA Represented At 6th Annual Army Force Health Protection Conference.Business Editors LOS ANGELES--(BUSINESS WIRE)--Sept. 9, 2003 Keynote Speaker, Dr. Adrian Ponce, Discusses Anthrax, Bio-Terror "Smoke" Detector Device Universal Detection Technology (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :UDTT) (Frankfurt:PRCC PRCC Pearl River Community College (Mississippi) PRCC Papillary Renal Cell Carcinoma PRCC Puerto Rican Cultural Center (Chicago, IL) PRCC Puerto Rico Convention Center PRCC Parallel Rural Community Curriculum .F), which recently announced that it had obtained the full funding needed to complete its research and development phase for its Bio-Terror Smoke Detector, was represented at the 6th annual Army Force Health Protection Conference held August 11-17 in Albuquerque, New Mexico “Albuquerque” redirects here. For other uses, see Albuquerque (disambiguation). Albuquerque (pronounced [ˈæl.bə.kɚ.kiː], Spanish: [al.βu. . Dr. Adrian Ponce, a lead scientist at NASA's Jet Propulsion Laboratory “JPL” redirects here. For other uses, see JPL (disambiguation). Jet Propulsion Laboratory (JPL) is a NASA research center located in the cities of Pasadena and La Cañada Flintridge, near Los Angeles, California, USA. (JPL (language) JPL - JAM Programming Language. ) and the inventor of the Anthrax 'Smoke' Detector, which is being developed by UDTT in conjunction with JPL, was the keynote speaker on the subject of bio-terrorism at this year's conference. Describing the technology being used to develop the unmanned Anthrax 'Smoke' Detector as "automated" and "devoid of false positive results," Dr. Ponce highlighted the need for rapid detection following the anthrax attacks of 2001. "The detection method combines an aerosol capture technique with bacterial spore bacterial spore, n a bacteria that, because of its thick outer wall, is easily able to survive in hostile environments otherwise not conducive to bacterial growth and reproduction. detection based on terbium terbium (tûr`bēəm) [from Ytterby, a village in Sweden], metallic chemical element; symbol Tb; at. no. 65; at. wt. 158.9254; m.p. 1,356°C;; b.p. 3,123°C;; sp. gr. about 8.25; valence +3 or +4. luminescence luminescence, general term applied to all forms of cool light, i.e., light emitted by sources other than a hot, incandescent body, such as a black body radiator. turn-on," explained Dr. Ponce. UDTT, which holds the exclusive option on all intellectual property related to the development of this device, believes this is a monumental occasion for the Company, and for that matter, the entire World. "Preliminary surveys show that a commercially available, unmanned, bio-terror 'smoke' detector may be received with an auspicious welcome at Post Offices, Airports, Casinos, Hotels, Theme Parks and Municipal Buildings world wide," said Jacques Tizabi President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Universal Detection Technology. About The Army Force Health Protection Conference The Army Force Health Protection Conference meets once a year to explore new advances in technology and information related to a "Fit and Ready Force," better sustain the soldier in garrison or during deployments, including those that involve Chemical, Biological, Radiological, Nuclear Explosives, or Weapons of Mass Destruction Weapons that are capable of a high order of destruction and/or of being used in such a manner as to destroy large numbers of people. Weapons of mass destruction can be high explosives or nuclear, biological, chemical, and radiological weapons, but exclude the means of transporting or , provide the skills needed to monitor the health of the soldier from accession to deployments and beyond, and to provide information of benefit to first responders. The conference was attended by some of the nations leading military and civilian experts. Military, Veterans Administration professionals, and Department of Defense civilian professionals working in the areas of occupational and preventive medicine, health promotion and wellness, population health, and behavioral health were also present. About Universal Detection Technology Universal Detection Technology (http://www.udetection.com), which recently had its ticker symbol changed from UDET to UDTT to accommodate a recent name change, was founded in 1973 and is a developer of monitoring technologies, including bio-terrorism detection devices. UDTT's technology, together with third party technologies and devices, positions the Company to capitalize on growth and value opportunities. Universal Detection Technology recently entered into an agreement with NASA NASA: see National Aeronautics and Space Administration. NASA in full National Aeronautics and Space Administration Independent U.S. Jet Propulsion Laboratory (JPL) to mutually develop a commercially available anthrax 'smoke' detector, which will combine the JPL spore detection technology with Universal's aerosol capture device. The partnership with Universal Detection Technology was accomplished through the Technology Affiliates Program, one of many Commercial Technology Programs aimed at transferring JPL knowledge to the private sector for broad public use. Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties include, among other things, the funding of amounts of capital adequate to provide for the working capital needs of the company, our ability to timely and cost effectively complete the development of our products targeted to the bio-chemical and medical markets, commercial acceptance of our products, product price volatility, product demand, market competition and general economic conditions, and other factors described in the company's filings with the securities and exchange commission. We undertake no obligation and do not intend to revise or update publicly any forward looking statements for any reason. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion